X 
Financials Ratios
Home | Market Info | Company Profile | Financials Ratios
Indo US Bio-Tech Ltd.
BSE CODE: 541304   |   NSE CODE: INDOUS   |   ISIN CODE : INE250Z01010   |   21-Nov-2024 Hrs IST
BSE NSE
Rs. 252.90
2.7 ( 1.08% )
 
Prev Close ( Rs.)
250.20
Open ( Rs.)
250.00
 
High ( Rs.)
257.00
Low ( Rs.)
250.00
 
Volume
114
Week Avg.Volume
353
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs. 246.65
-5 ( -1.99% )
 
Prev Close ( Rs.)
251.65
Open ( Rs.)
252.45
 
High ( Rs.)
258.70
Low ( Rs.)
242.30
 
Volume
4401
Week Avg.Volume
5698
 
52 WK High-Low Range(Rs.)
222
331.8
Particulars Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Operational & Financial Ratios          
   Earnings Per Share (Rs)4.12  7.22  5.71  8.40  4.18  
   CEPS(Rs)4.51  4.02  3.09  3.67  1.89  
   DPS(Rs)0.00  0.00  0.00  0.00  0.00  
   Book NAV/Share(Rs)31.29  54.35  42.41  35.47  27.05  
   Tax Rate(%)6.28  1.98  4.60  -23.53  11.49  
Margin Ratios          
   Core EBITDA Margin(%)14.83  15.21  13.85  13.75  9.97  
   EBIT Margin(%)14.17  13.91  13.37  13.24  9.43  
   Pre Tax Margin(%)12.09  11.96  10.97  10.29  7.20  
   PAT Margin (%)11.33  11.73  10.46  12.72  6.37  
   Cash Profit Margin (%)12.43  13.06  11.31  13.34  6.91  
Performance Ratios          
   ROA(%)10.81  11.67  10.63  13.05  8.66  
   ROE(%)14.08  15.51  17.34  26.87  16.74  
   ROCE(%)14.42  14.62  15.86  18.30  16.65  
   Asset Turnover(x)0.95  1.00  1.02  1.03  1.36  
   Sales/Fixed Asset(x)10.36  9.57  12.72  21.43  19.95  
   Working Capital/Sales(x)1.31  1.30  1.44  1.99  2.62  
Efficiency Ratios          
   Fixed Capital/Sales(x)0.10  0.10  0.08  0.05  0.05  
   Receivable days109.71  133.85  164.93  207.92  137.87  
   Inventory Days197.06  148.59  128.48  95.73  91.16  
   Payable days-53.89  302.49  -222.52  0.00  418.37  
Valuation Parameters          
   PER(x)53.94  14.71  5.91  3.23  10.24  
   PCE(x)49.17  26.41  10.93  3.69  11.34  
   Price/Book(x)7.09  3.91  1.59  0.92  1.90  
   Yield(%)0.00  0.00  0.00  0.00  0.00  
   EV/Net Sales(x)6.29  3.64  1.48  0.78  0.99  
   EV/Core EBITDA(x)41.20  23.84  10.45  5.60  9.96  
   EV/EBIT(x)44.39  26.14  11.11  5.86  10.55  
   EV/CE(x)5.95  3.40  1.35  0.72  1.14  
   M Cap / Sales6.11  3.45  1.24  0.49  0.78  
Growth Ratio          
   Net Sales Growth(%)17.96  23.36  24.86  0.82  12.03  
   Core EBITDA Growth(%)18.17  32.33  28.02  39.92  15.23  
   EBIT Growth(%)20.21  28.35  26.10  41.59  16.89  
   PAT Growth(%)13.96  38.25  2.73  101.13  21.38  
   EPS Growth(%)-43.02  26.40  -31.99  101.13  -2.90  
Financial Stability Ratios          
   Total Debt/Equity(x)0.23  0.21  0.32  0.53  0.52  
   Current Ratio(x)4.19  4.87  3.85  2.12  1.91  
   Quick Ratio(x)1.22  2.68  1.94  1.46  1.36  
   Interest Cover(x)6.79  7.15  5.57  4.50  4.24  
   Total Debt/Mcap(x)0.03  0.05  0.20  0.58  0.28